User talk:Valsartan18

Welcome
Hello, Valsartan18 and welcome to Wikipedia! It appears you are participating in a class project. If you haven't done so already, we encourage you to go through our training for students.

If you need help, check out Questions, ask me on, or ask your question on this page and then place  before the question. Please also read this helpful advice for students.

Before you create an article, make sure you understand what kind of articles are accepted here. Remember: Wikipedia is an encyclopedia, and while many topics are encyclopedic, some things are not.

Your instructor or professor may wish to set up a course page, and if your class doesn't already have one please tell your instructor about that. It is highly recommended that you place this text:  on the talk page of any articles you are working on as part of your Wikipedia-related course assignment. This will let other editors know this article is a subject of an educational assignment and aid your communication with them.

We hope you like it here and encourage you to stay even after your assignment is finished! Drm310 (talk) 19:57, 27 October 2015 (UTC)

Valsartan18, you are invited on a Wikipedia Adventure!
 The Adventure

Welcome!
Hello, Valsartan18, and welcome to Wikipedia! My name is Ian and I work with the Wiki Education Foundation; I help support students who are editing as part of a class assignment.

I hope you enjoy editing here. If you haven't already done so, please complete the student training, which introduces you to editing and Wikipedia's core principles. You may also want to check out the Teahouse, a community of Wikipedia editors dedicated to helping new users. Below are some resources to help you get started editing. If you have any questions, please don't hesitate to contact me on my talk page. Ian (Wiki Ed) (talk) 21:56, 29 October 2015 (UTC)

Valsartan article edit
Hi all, this is Group 18 from CP133 2015 at UCSF School of Pharmacy. Some edits we have made: 1. expanding the side effects to include percentages in both heart failure and hypertension 2. expanding the mechanism of action section 3. removed possibly unreliable details in the economics section and updated the section with details from the Novartis 2010 report 4. edited certain words (patient --> person) to improve readability 5. updated the link for the Canadian labeling regarding breast feeding